21 results for author:"Eferl R." in Literature citations
Results Customize
› Repeat search in UniProtKB (2)
| PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas. Laimer D., Dolznig H., Kollmann K., Vesely P.W., Schlederer M., Merkel O., Schiefer A.I., Hassler M.R., Heider S., Amenitsch L. et al. Nat. Med. 18:1699-1704(2012) · Mapped (27) |
| NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development. Sancho P., Mainez J., Crosas-Molist E., Roncero C., Fernandez-Rodriguez C.M., Pinedo F., Huber H., Eferl R., Mikulits W., Fabregat I. PLoS ONE 7:e45285-e45285(2012) · Mapped (4) |
| p19(ARF) /p14(ARF) controls oncogenic functions of signal transducer and activator of transcription 3 in hepatocellular carcinoma. Schneller D., Machat G., Sousek A., Proell V., van Zijl F., Zulehner G., Huber H., Mair M., Muellner M.K., Nijman S.M. et al. Hepatology 54:164-172(2011) · Mapped (14) |
| A mouse tool for conditional mutagenesis in ovarian granulosa cells. Grabner B., Blaas L., Musteanu M., Hoffmann T., Birbach A., Eferl R., Casanova E. Genesis 48:612-617(2010) · Mapped (7) |
| Signal transducer and activator of transcription 3 protects from liver injury and fibrosis in a mouse model of sclerosing cholangitis. Mair M., Zollner G., Schneller D., Musteanu M., Fickert P., Gumhold J., Schuster C., Fuchsbichler A., Bilban M., Tauber S. et al. Gastroenterology 138:2499-2508(2010) · Mapped (7) |
| Disruption of the growth hormone--signal transducer and activator of transcription 5--insulinlike growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasis. Blaas L., Kornfeld J.W., Schramek D., Musteanu M., Zollner G., Gumhold J., van Zijl F., Schneller D., Esterbauer H., Egger G. et al. Hepatology 51:1319-1326(2010) · Mapped (17) |
| Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice. Musteanu M., Blaas L., Mair M., Schlederer M., Bilban M., Tauber S., Esterbauer H., Mueller M., Casanova E., Kenner L. et al. Gastroenterology 138:1003-11.e1-5(2010) · Mapped (7) |
| Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1. Eferl R., Hasselblatt P., Rath M., Popper H., Zenz R., Komnenovic V., Idarraga M.H., Kenner L., Wagner E.F. Proc. Natl. Acad. Sci. U.S.A. 105:10525-10530(2008) · Mapped (9) |
| Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia. Bozec A., Bakiri L., Hoebertz A., Eferl R., Schilling A.F., Komnenovic V., Scheuch H., Priemel M., Stewart C.L., Amling M. et al. |
| Simultaneous generation of fra-2 conditional and fra-2 knock-out mice. Eferl R., Zenz R., Theussl H.C., Wagner E.F. Genesis 45:447-451(2007) · Mapped (1) |
| c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity. Stepniak E., Ricci R., Eferl R., Sumara G., Sumara I., Rath M., Hui L., Wagner E.F. Genes Dev. 20:2306-2314(2006) · Mapped (28) |
| Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Zenz R., Eferl R., Kenner L., Florin L., Hummerich L., Mehic D., Scheuch H., Angel P., Tschachler E., Wagner E.F. Nature 437:369-375(2005) · Mapped (10) |
| Distinct functions of junD in cardiac hypertrophy and heart failure. Ricci R., Eriksson U., Oudit G.Y., Eferl R., Akhmedov A., Sumara I., Sumara G., Kassiri Z., David J.P., Bakiri L. et al. Genes Dev. 19:208-213(2005) · Mapped (8) |
| The AP1 transcription factor Fra2 is required for efficient cartilage development. Karreth F., Hoebertz A., Scheuch H., Eferl R., Wagner E.F. Development 131:5717-5725(2004) · Mapped (7) |
| The Fos-related antigen Fra-1 is an activator of bone matrix formation. Eferl R., Hoebertz A., Schilling A.F., Rath M., Karreth F., Kenner L., Amling M., Wagner E.F. EMBO J. 23:2789-2799(2004) · Mapped (6) |
| Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects. Kenner L., Hoebertz A., Beil F.T., Beil T., Keon N., Karreth F., Eferl R., Scheuch H., Szremska A., Amling M. et al. J. Cell Biol. 164:613-623(2004) · Mapped (8) |
| Rhabdomyosarcoma development in mice lacking Trp53 and Fos: tumor suppression by the Fos protooncogene. Fleischmann A., Jochum W., Eferl R., Witowsky J., Wagner E.F. Cancer Cell 4:477-482(2003) · Mapped (14) |
| c-Jun regulates eyelid closure and skin tumor development through EGFR signaling. Zenz R., Scheuch H., Martin P., Frank C., Eferl R., Kenner L., Sibilia M., Wagner E.F. Dev. Cell 4:879-889(2003) · Mapped (16) |
| Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Eferl R., Ricci R., Kenner L., Zenz R., David J.P., Rath M., Wagner E.F. Cell 112:181-192(2003) · Mapped (23) |
| cDNA cloning and analysis of tissue-specific expression of mouse peroxisomal straight-chain acyl-CoA oxidase. Nohammer C., El-Shabrawi Y., Schauer S., Hiden M., Berger J., Forss-Petter S., Winter E., Eferl R., Zechner R., Hoefler G. Eur. J. Biochem. 267:1254-1260(2000) · UniProtKB (1) · Mapped (3) |
| Functions of c-Jun in liver and heart development. Eferl R., Sibilia M., Hilberg F., Fuchsbichler A., Kufferath I., Guertl B., Zenz R., Wagner E.F., Zatloukal K. J. Cell Biol. 145:1049-1061(1999) · Mapped (56) |